Filter
387
Filtered Results: 387
Text search:
Shigella
Featured
Recommendations
49
New Publications
96
Language
Document type
No document type
202
Guidelines
76
Studies & Reports
42
Manuals
21
Fact sheets
13
Strategic & Response Plan
12
Training Material
10
Situation Updates
9
Infographics
2
Countries / Regions
India
16
Congo, Democratic Republic of
11
Africa
11
Rwanda
9
South Africa
9
Liberia
8
Senegal
8
Ethiopia
8
Nepal
7
Germany
7
Kenya
7
Tanzania
7
Latin America and the Carribbean
7
Burkina Faso
6
Nigeria
6
Western and Central Europe
6
Philippines
5
Bangladesh
5
Guinea
4
Sierra Leone
4
Uganda
4
Zimbabwe
4
Mozambique
4
Ukraine
4
Paraguay
4
Global
4
Mali
3
Ghana
3
Malawi
3
Myanmar / Burma
3
Côte d’Ivoire / Ivory Coast
2
Haiti
2
Syria
2
Argentina
2
Peru
2
Yemen
2
West and Central Africa
2
Russia
2
Guinea-Bissau
1
Morocco
1
Cameroon
1
Niger
1
Togo
1
Pakistan
1
Jordan
1
Afghanistan
1
Zambia
1
Chad
1
Cambodia
1
Thailand
1
Indonesia
1
Papua New Guinea
1
Brazil
1
North Macedonia
1
Colombia
1
Bolivia
1
Angola
1
Madagascar
1
Lesotho
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Iran
1
Vietnam
1
Uruguay
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
127
Clinical Guidelines
53
Women & Child Health
32
Key Resources
31
Capacity Building
15
Public Health
12
Pharmacy & Technologies
9
Toolboxes
AMR
75
Rapid Response
39
Ebola
28
Cholera
27
Pharmacy
23
Planetary Health
12
HIV
10
Natural Hazards
9
Refugee
8
Caregiver
8
Conflict
7
TB
6
COVID-19
6
Global Health Education
3
Mental Health
2
NTDs
2
Zika
1
Specific Hazards
1
NCDs
1
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
La résistance à un antimicrobien survient quand un micro-organisme (bactérie, virus, champignon ou parasite), devient résistant à un médicament antimicrobien vis-à-vis duquel il était auparavant sensible . Cette résistance aux antimicrobiens (RAM), concerne un large ...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Antibiotic resistance is no longer a concern for the distant future but is a pressing issue, both globally and in Nepal. As part of global effort to preserve the effectiveness of antibiotics, the Global Antibiotic Resistance Partnership (GARP)-Nepal was established to doc...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory infections, diar...
Infection Prevention and Control Programmes
January 2020
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Manuel sur la PCIME
recommended
La prise en chargeintégrée des maladiesde l’enfant
Blended Learning Modulef or the Health Extension Programme
In this study session, you will learn about the general features of faeco-oraldiseases: the main types commonly found in Ethiopia, their general symptomsand signs, how to treat mild cases and when to refer patients with severeconditions for...
